SCHEMBL328478

SCHEMBL328478

CCCCCCC(=O)N(C)CCN(CC(N)=O)S(=O)(=O)c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
CNR2 P34972 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
DAGLA Q9Y4D2 2/20 0.33
THRB P10828 2/20 0.33
VCAM1 P19320 2/20 0.33
SLC9A3 P48764 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
BMP1 P13497 1/20 0.32
PNLIP P16233 1/20 0.32
MMP3 P08254 1/20 0.32
THRA P10827 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6863158 0.90 MMP3 (0.43) LMNACA1CA9THRBBMP1
SCHEMBL6852303 0.82 ADRB2 (0.38) LMNA
SCHEMBL328414 0.82 DAGLA (0.37) CA12CA1CA9DAGLATHRB
SCHEMBL6850664 0.81 DAGLA (0.43) DAGLASLC9A3
SCHEMBL328661 0.81 KMT2A (0.38) CA12CA1CA9DAGLATHRB
SCHEMBL328548 0.81 DAGLA (0.37) CA12CA1CA9DAGLATHRB
SCHEMBL328658 0.80 HSP90AA1 (0.41) LMNACA12CA1CA9DAGLA
SCHEMBL328659 0.80 RORC (0.40)
SCHEMBL6852280 0.79 BDKRB1 (0.40) CA12CA1CA9DAGLATHRB
SCHEMBL10066710 0.79 LSS (0.41) CA12CA1CA9DAGLASLC9A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428509-A1 Human adam-10 inhibitors Symphony Evolution, Inc. (US) 2012-03-14 EP disclosed
WO-2011011181-A1 PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AMICUS THERAPEUTICS, INC. (US) 2011-01-27 WO disclosed